144809-41-6

Upstream product

• 1117-71-1 methyl-4-bromo-2-butenoate 
• 768-56-9 4-Phenylbut-1-ene 
• 16387-61-4 6-phenylhexanal 
• 21204-67-1 methyl (triphenylphosphoranylidene)acetate 

Downstream Products

• 370064-84-9 1-(3-(S)-benzyloxyamino-8-phenyloctanoyl)-3,4-(S)-dimethyl-5-(R)-phenylimidazolidin-2-one 
• 370064-93-0 1-(4-methoxybenzenesulfonyl)-3-(S)-(5-phenylpentyl)aziridine-2-(R)-carboxylic acid benzyloxyamide 
• 370064-90-7 1-(4-methoxybenzenesulfonyl)-3-(S)-(5-phenylpentyl)aziridine-2-(R)-carboxylic acid benzyl ester 
• 370064-86-1 1,5-(S)-dimethyl-4-(R)-pheny-3-[3-(S)-(5-phenylpentyl)-aziridine-2-(R)-carbonyl]-imidazolidin-2-one 
• 370064-82-7 (E)-1,5-(S)-dimethyl-4-(R)-phenyl-3-(9-phenyloct-2-enoyl)imidazolidin-2-one 
• 370064-92-9 1-(4-methoxybenzenesulfonyl)-3-(S)-(5-phenylpentyl)aziridine-2-(R)-carboxylic acid 
• 370064-88-3 3-(S)-(5-phenylpentyl)-aziridine-2-(R)-carboxylic acid benzyl ester 
• 370064-80-5 (E)-8-phenyloct-2-enoic acid 

Relevant academic research and scientific papers

Design and synthesis of MMP inhibitors using N-arylsulfonylaziridine hydroxamic acids as constrained scaffolds

The synthesis of cis- and trans-aziridine hydroxamic acid derivatives as MMP inhibitors is described using enantio- and diastereoselective methods for the formation of trisubstituted aziridines. Their preliminary inhibitory activity is reported and discus

Copper-catalyzed allylic alkylations of alkylzirconium intermediates

Hydrozirconation of olefins followed by exposure of the resulting alkylzirconium species to catalytic CuCN in the presence of activated halides or phosphonates gives rise to products of aklkylation in good yields under mild conditions.